Literature DB >> 11470266

Oligosaccharyltransferase is highly specific for the hydroxy amino acid in Asn-Xaa-Thr/Ser.

W Breuer1, R A Klein, B Hardt, A Bartoschek, E Bause.   

Abstract

Pig liver oligosaccharyltransferase (OST), which is involved in the en bloc transfer of the Dol-PP-linked GlcNAc(2)-Man(9)-Glc(3) precursor on to asparagine residues in the Asn-Xaa-Thr/Ser sequence, is highly stereospecific for the conformation of the 3-carbon atom in the hydroxy amino acid. Moreover, substitution of the hydroxy group by either SH as in cysteine, or NH(2) as in beta,gamma-diamino-butanoic acid as reported previously [Bause, E. et al., Biochem. J. 312 (1995) 979-985], followed by the determination of the pH optimum for enzymatic activity, indicates that neither a negative nor a positive charge in the hydroxy amino acid position is tolerated by the enzyme. Binding of the threonine beta-methyl group by OST is also specific, with serine, L-threo-beta-hydroxynorvaline and L-beta-hydroxynorleucine containing tripeptides all bound much less efficiently than the threonine peptide itself. The data are interpreted in terms of a highly stereospecific hydrophobic binding pocket for the threonine CH(3)-CH(OH) group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470266     DOI: 10.1016/s0014-5793(01)02641-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  X-ray structure of a bacterial oligosaccharyltransferase.

Authors:  Christian Lizak; Sabina Gerber; Shin Numao; Markus Aebi; Kaspar P Locher
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

2.  Post-translational N-glycosylation of type I transmembrane KCNE1 peptides: implications for membrane protein biogenesis and disease.

Authors:  Tuba Bas; Grace Y Gao; Anatoli Lvov; Kshama D Chandrasekhar; Reid Gilmore; William R Kobertz
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

3.  Glutamine-linked and non-consensus asparagine-linked oligosaccharides present in human recombinant antibodies define novel protein glycosylation motifs.

Authors:  John F Valliere-Douglass; Catherine M Eakin; Alison Wallace; Randal R Ketchem; Wesley Wang; Michael J Treuheit; Alain Balland
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

4.  Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses.

Authors:  Jike Cui; Temple Smith; Phillips W Robbins; John Samuelson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

Review 5.  Effects of N-glycan precursor length diversity on quality control of protein folding and on protein glycosylation.

Authors:  John Samuelson; Phillips W Robbins
Journal:  Semin Cell Dev Biol       Date:  2014-12-02       Impact factor: 7.727

6.  Changes in the N-glycome, glycoproteins with Asn-linked glycans, of Giardia lamblia with differentiation from trophozoites to cysts.

Authors:  Daniel M Ratner; Jike Cui; Martin Steffen; Landon L Moore; Phillips W Robbins; John Samuelson
Journal:  Eukaryot Cell       Date:  2008-09-26

7.  Molecular determinants of co- and post-translational N-glycosylation of type I transmembrane peptides.

Authors:  Heidi L H Malaby; William R Kobertz
Journal:  Biochem J       Date:  2013-08-01       Impact factor: 3.857

8.  Asparagine-linked oligosaccharides present on a non-consensus amino acid sequence in the CH1 domain of human antibodies.

Authors:  John F Valliere-Douglass; Paul Kodama; Mirna Mujacic; Lowell J Brady; Wes Wang; Alison Wallace; Boxu Yan; Pranhitha Reddy; Michael J Treuheit; Alain Balland
Journal:  J Biol Chem       Date:  2009-09-18       Impact factor: 5.157

Review 9.  N-linked protein glycosylation in the endoplasmic reticulum.

Authors:  Jörg Breitling; Markus Aebi
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

10.  Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain.

Authors:  Suman R Das; Pere Puigbò; Scott E Hensley; Darrell E Hurt; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.